title: A novel Sin Nombre virus DNA vaccine and its inclusion in a candidate pan-hantavirus vaccine against hantavirus pulmonary syndrome (HPS) and hemorrhagic fever with renal syndrome (HFRS).
abstract: Sin Nombre virus (SNV; family Bunyaviridae, genus Hantavirus) causes a hemorrhagic fever known as hantavirus pulmonary syndrome (HPS) in North America. There have been approximately 200 fatal cases of HPS in the United States since 1993, predominantly in healthy working-age males (case fatality rate 35%). There are no FDA-approved vaccines or drugs to prevent or treat HPS. Previously, we reported that hantavirus vaccines based on the full-length M gene segment of Andes virus (ANDV) for HPS in South America, and Hantaan virus (HTNV) and Puumala virus (PUUV) for hemorrhagic fever with renal syndrome (HFRS) in Eurasia, all elicited high-titer neutralizing antibodies in animal models. HFRS is more prevalent than HPS (>20,000 cases per year) but less pathogenic (case fatality rate 1-15%). Here, we report the construction and testing of a SNV full-length M gene-based DNA vaccine to prevent HPS. Rabbits vaccinated with the SNV DNA vaccine by muscle electroporation (mEP) developed high titers of neutralizing antibodies. Furthermore, hamsters vaccinated three times with the SNV DNA vaccine using a gene gun were completely protected against SNV infection. This is the first vaccine of any kind that specifically elicits high-titer neutralizing antibodies against SNV. To test the possibility of producing a pan-hantavirus vaccine, rabbits were vaccinated by mEP with an HPS mix (ANDV and SNV plasmids), or HFRS mix (HTNV and PUUV plasmids), or HPS/HFRS mix (all four plasmids). The HPS mix and HFRS mix elicited neutralizing antibodies predominantly against ANDV/SNV and HTNV/PUUV, respectively. Furthermore, the HPS/HFRS mix elicited neutralizing antibodies against all four viruses. These findings demonstrate a pan-hantavirus vaccine using a mixed-plasmid DNA vaccine approach is feasible and warrants further development.
authors.affiliation: Virology Division, United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, MD 21702, USA. Jay.W.Hooper@us.army.mil
authors.forename: Jay W
authors.initials: JW
authors.lastname: Hooper
authors.forename: Matthew
authors.initials: M
authors.lastname: Josleyn
authors.forename: John
authors.initials: J
authors.lastname: Ballantyne
authors.forename: Rebecca
authors.initials: R
authors.lastname: Brocato
mesh_terms: D000818:Animals; D057134:Antibodies, Neutralizing / Q000097:blood; D000914:Antibodies, Viral / Q000097:blood; D002460:Cell Line; D002522:Chlorocebus aethiops; D006224:Cricetinae; D018274:Electroporation; D005260:Female; D018063:Hantaan virus / Q000276:immunology; D018804:Hantavirus Pulmonary Syndrome / Q000276:immunology* / Q000517:prevention & control; D006480:Hemorrhagic Fever with Renal Syndrome / Q000276:immunology* / Q000517:prevention & control; D029262:Puumala virus; D011817:Rabbits; D029261:Sin Nombre virus / Q000235:genetics / Q000276:immunology*; D014611:Vaccination / Q000379:methods; D019444:Vaccines, DNA / Q000627:therapeutic use*; D014709:Vero Cells
chemical_list: D057134:Antibodies, Neutralizing; D000914:Antibodies, Viral; D019444:Vaccines, DNA
keywords: DNA vaccine; HFRS; HPS; Hantavirus; Sin Nombre virus; mEP; muscle electroporation
references.citation: Virology. 1995 Feb 1;206(2):963-72
references.pmid: 7856107
references.citation: Arch Virol. 1989;105(3-4):235-46
references.pmid: 2568827
references.citation: PLoS One. 2011 Mar 03;6(3):e17596
references.pmid: 21408612
references.citation: Clin Vaccine Immunol. 2011 May;18(5):707-16
references.pmid: 21450977
references.citation: Emerg Infect Dis. 2004 Mar;10(3):478-82
references.pmid: 15109416
references.citation: Eur J Cardiothorac Surg. 2011 Dec;40(6):1334-40
references.pmid: 21900022
references.citation: J Clin Microbiol. 1997 May;35(5):1122-30
references.pmid: 9114393
references.citation: Virology. 1996 Mar 1;217(1):262-71
references.pmid: 8599211
references.citation: J Virol. 2001 Sep;75(18):8469-77
references.pmid: 11507192
references.citation: MMWR Morb Mortal Wkly Rep. 1993 Jun 11;42(22):421-4
references.pmid: 8502213
references.citation: Virus Res. 1993 Oct;30(1):97-103
references.pmid: 8266723
references.citation: Vaccine. 1999 Jul 16;17(22):2836-43
references.pmid: 10438054
references.citation: J Clin Microbiol. 2000 Aug;38(8):3029-35
references.pmid: 10921972
references.citation: Antivir Ther. 2008;13(1):125-33
references.pmid: 18389907
references.citation: J Virol. 2008 Feb;82(3):1332-8
references.pmid: 18032485
references.citation: J Virol. 2003 Jan;77(2):1540-50
references.pmid: 12502867
references.citation: J Virol. 2003 Sep;77(18):9894-905
references.pmid: 12941899
references.citation: Biochem Biophys Res Commun. 2002 Nov 8;298(4):552-8
references.pmid: 12408987
references.citation: Arch Virol. 1992;126(1-4):271-81
references.pmid: 1381911
references.citation: Virology. 1999 Mar 15;255(2):269-78
references.pmid: 10069952
references.citation: Clin Vaccine Immunol. 2013 Feb;20(2):218-26
references.pmid: 23239797
references.citation: Am J Trop Med Hyg. 1994 Jul;51(1):102-8
references.pmid: 8059907
references.citation: MMWR Morb Mortal Wkly Rep. 2012 Nov 23;61(46):952
references.pmid: 23169317
references.citation: Vaccine. 2008 Sep 19;26(40):5177-81
references.pmid: 18482782
references.citation: Annu Rev Med. 1999;50:531-45
references.pmid: 10073292
references.citation: J Gen Virol. 2007 Feb;88(Pt 2):493-505
references.pmid: 17251568
references.citation: Vaccine. 2012 Mar 2;30(11):1951-8
references.pmid: 22248821
references.citation: Virology. 2001 Oct 10;289(1):6-14
references.pmid: 11601912
references.citation: J Infect Dis. 1978 Mar;137(3):298-308
references.pmid: 24670
references.citation: MMWR Morb Mortal Wkly Rep. 1993 Jul 2;42(25):495-6
references.pmid: 8510636
references.citation: J Gen Virol. 2002 Jul;83(Pt 7):1745-1751
references.pmid: 12075094
references.citation: Virology. 2006 Mar 30;347(1):208-16
references.pmid: 16378630
references.citation: PLoS One. 2012;7(4):e35996
references.pmid: 22558299
references.citation: J Thorac Cardiovasc Surg. 2008 Mar;135(3):579-84
references.pmid: 18329474